Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements (“REE”), today announced its entry into a definitive agreement to sell three wholly owned subsidiaries that together hold its Alta Mesa ISR Project to enCore Energy for total consideration of $120 million (the “transaction”). The transaction, which is…
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, has announced financial results for the third quarter ended Sept. 30, 2022, and year-to-date ended Sept. 30, 2022. Among the highlights, the company reported $2,312,577 in total revenue for the three months ended Sept. 30, 2022,…
Tingo (OTC: TMNA) today announced that it has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three and nine months ended Sept. 30, 2022. Among the highlights, the company reported growth in its Nwassa agri-fintech business that has driven increases of 64.8 % in revenues and 53.9…
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is working with the 357 Company to launch 357’s Canna Logistics division. The new division is an expansion beyond 357’s Hemp Logistics segment, which ships federally legal hemp within the United States. According to the announcement, the new division…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for…
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, appears to have a strong position to expedite growth as it remains committed to delivering on its ambitious goals for a more sustainable future. “EverGen Infrastructure has announced that its wholly owned subsidiary Fraser Valley Biogas…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced initial dosing in its IND-enabling study of SP-26, its novel time-released, topical formulation of ketamine. According to the update, the objective of this safety evaluation study, conducted by Experimur (a Frontage Company), is to evaluate the…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at Legacy Emanuel Medical Center in Portland, Oregon, for the Violence in the Workplace Prevention Summit on Nov. 11, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with…
Mullen Automotive’s (NASDAQ: MULN) majority owned company, Bollinger Motors, today announced that Our Next Energy will be supplying modular, linkable Aries battery packs to power its all-electric commercial platforms and chassis cabs. Bollinger’s all-electric Class 4 through Class 6 chassis cabs are designed to meet the needs of commercial customers in a segment that often…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is starting a new study program — DEM-A22-1 — on Nov. 15, 2022. The study, a first for Lexaria, will evaluate whether LEXX’s DehydraTECH-processed cannabidiol (“CBD”) may have potential for therapeutic treatment for dementia. According to the announcement, Lexaria has previously shown the efficacy of…
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is one step closer to completing its previously announced acquisition of Franchise Global Health (TSX.V: FGH). FLGC announced that holders of more than 73% of the outstanding shares of FGH have agreed to vote their shares in favor of…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,”…
Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has activated more machines across the country. According to the announcement, the deployed equipment consists of ASRs and one of Knightscope’s newest products, the K1 Blue Light Tower. Deployment locations include another California resort and casino, a privately owned global real estate…
Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has filed a Definitive Information Statement with the U.S. Securities and Exchange Commission (“SEC”). The statement outlines the completion of the merger between Tingo Mobile PLC, a wholly owned Tingo subsidiary, with MICT Inc., a NASDAQ-traded financial technology company; the merger should be complete by the end…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has signed an agreement to deploy 22 K1 Blue Light Towers at a Florida college. According to the announcement, many schools are ill-equipped to address campus safety challenges because of staffing shortages and budget constraints. Knightscope’s proprietary tech and devices provide key solutions to…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety…
CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the…
Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as of Sept. 30, 2022, including $77.1 million of cash and cash equivalents, $11.6 million of marketable securities, $27.3 million of…